Structure-Activity Relationship Study of Heterocyclic Phenylethenyl and Pyridinylethenyl Derivatives as Tau-Imaging Agents That Selectively Detect Neurofibrillary Tangles in Alzheimer's Disease Brains

Journal of Medicinal Chemistry
Kenji MatsumuraHideo Saji

Abstract

In order to explore novel tau-imaging agents that can selectively detect neurofibrillary tangles in Alzheimer's disease (AD) brains, we designed and synthesized a series of heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives with or without a dimethyl amino group. In in vitro autoradiography using AD brain sections, all radioiodinated ligands with a dimethyl amino group bound to Aβ deposits in the sections. In contrast, the ligands without a dimethyl amino group showed different patterns of radioactivity accumulation in the sections depending on the kind of heterocycle contained in their molecules. Particularly, a phenylethenyl benzimidazole derivative ([(125)I]64) showed marked radioactivity accumulation in the temporal lobe which corresponded with the distribution of tau deposits. [(125)I]64 also showed the most favorable pharmacokinetics in normal mouse brains (3.69 and 0.06% ID/g at 2 and 60 min postinjection, respectively) among all ligands in this study. Taken together, these results suggest that [(123)I]64 may be a new candidate tau-imaging agent.

References

Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
May 11, 2005·Neurology·S GilmanUNKNOWN AN1792(QS-21)-201 Study Team
Nov 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nobuyuki OkamuraYukitsuka Kudo
Sep 1, 2007·Neurobiology of Disease·Nicolette S HonsonJeff Kuret
Nov 13, 2008·Archives of Neurology·Howard Jay AizensteinWilliam E Klunk
Mar 20, 2009·Annals of Neurology·Leslie M ShawUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Apr 3, 2009·Brain : a Journal of Neurology·Clifford R JackUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Ron BrookmeyerH Michael Arrighi
Jul 21, 2009·Trends in Pharmacological Sciences·Victor W Pike
Oct 23, 2009·Journal of Medicinal Chemistry·Hank F KungDaniel Skovronsky
Dec 1, 2009·Journal of Neurology·Katsutoshi FurukawaHiroyuki Arai
Jan 20, 2010·Lancet Neurology·Clifford R JackJohn Q Trojanowski
May 1, 2010·Nature Reviews. Drug Discovery·Martin Citron
Jan 20, 2011·JAMA : the Journal of the American Medical Association·Christopher M ClarkUNKNOWN AV45-A07 Study Group
Apr 11, 2012·Journal of Neuropathology and Experimental Neurology·Peter T NelsonThomas G Beach
Jun 12, 2012·Journal of Alzheimer's Disease : JAD·Wei ZhangHartmuth C Kolb
May 18, 2011·ACS Chemical Neuroscience·Masahiro OnoHideo Saji
Jul 18, 2012·European Journal of Nuclear Medicine and Molecular Imaging·Anniina SnellmanMerja Haaparanta-Solin
Jul 27, 2012·Bioorganic & Medicinal Chemistry Letters·Hiroyuki WatanabeHideo Saji
Aug 29, 2012·Photochemistry and Photobiology·Anasuya MishraGovindarajan Krishnamoorthy
Sep 1, 2012·Nature Reviews. Drug Discovery·Asher Mullard
Oct 3, 2012·Seminars in Nuclear Medicine·Chester A MathisWilliam E Klunk
Dec 14, 2012·Journal of Alzheimer's Disease : JAD·David T ChienHartmuth C Kolb
Feb 16, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Chun-Fang XiaHartmuth C Kolb
Apr 12, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Christopher C RoweVictor L Villemagne
Jul 17, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Nobuyuki OkamuraYukitsuka Kudo
Jul 23, 2013·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Ryuichi HaradaYukitsuka Kudo
Aug 21, 2013·Journal of Alzheimer's Disease : JAD·David T ChienHartmuth C Kolb
Nov 30, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Kevin M FelsensteinDavid R Borchelt
Apr 1, 2014·Brain : a Journal of Neurology·Nobuyuki OkamuraVictor L Villemagne
Jun 26, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Hiroki HashimotoMing-Rong Zhang
Dec 9, 2014·ACS Chemical Neuroscience·Behrooz Hooshyar YousefiHans-Jürgen Wester
Mar 21, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Ryuichi HaradaYukitsuka Kudo

❮ Previous
Next ❯

Citations

Jan 12, 2016·Biomolecules·Ryuichi HaradaYukitsuka Kudo
Jan 24, 2016·Ageing Research Reviews·Nobuyuki OkamuraYukitsuka Kudo
Nov 24, 2016·Current Neurology and Neuroscience Reports·Diana A OlszewskaTim Lynch
Aug 15, 2018·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Chengyu LiHirofumi Maruyama
Nov 3, 2017·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Hiroyuki Watanabe
Oct 3, 2017·Biological & Pharmaceutical Bulletin·Hideo Saji
Jan 27, 2019·Current Medicinal Chemistry·Hayrettin Ozan GulcanIlkay Erdogan Orhan
Nov 30, 2016·Faraday Discussions·Wei-Tao DouHe Tian
Nov 9, 2018·Molecular Pharmaceutics·Hiroyuki WatanabeHideo Saji

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.